Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T08:22:15.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content and blocking access to the ClinicalTrials.gov entry; as a result, the detailed study information is no longer visible on the page.
    Difference
    19%
    Check dated 2026-09-22T03:28:44.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing v3.6.5, indicating a small system update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:31:10.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page's metadata or structure rather than content changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-10T12:46:56.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4. This indicates a minor page update without changes to substantive content.
    Difference
    0.1%
    Check dated 2026-07-27T05:49:43.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Revision updated to v3.6.3, signaling a minor page update. The content and study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-05T11:31:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.